O. Javizian
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
O. Javizian has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Aliyah Pabani
The Sidney Kimmel Comprehensive Cancer Center 1 , Johns Hopkins University School of Medicine, Baltimore, Maryland
1 shared publication - D. Gwyn Bebb
Medical Oncology, Alberta Health Services - Tom Baker Cancer Centre, Calgary/AB/CA
1 shared publication - Daniel E. Meyers
CancerCare Manitoba, Winnipeg, MB R3E 0V9, Canada
1 shared publication - Derek W. Morris
School of Biological and Chemical Sciences, University of Galway, H91 TK33 Galway, Ireland
1 shared publication H. Grosjean
Cumming School of Medicine, University of Calgary, Calgary/AB/CA
1 shared publication- Igor Stukalin
Division of Gastroenterology and Hepatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada
1 shared publication
Latest Publications
- 1 March 2021
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 16 (3) , S290
P09.08 Age-Related Outcomes of First-Line Pembrolizumab in a Real-World Non-Small-Cell Lung Cancer (NSCLC) Cohort
- 1 March 2021
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 16 (3) , S290
P09.08 Age-Related Outcomes of First-Line Pembrolizumab in a Real-World Non-Small-Cell Lung Cancer (NSCLC) Cohort
- 26 February 2017
- Published by Wiley in European Journal of Neurology
- Vol. 24 (4) , 624-630
Smoking does not influence disability accumulation in primary progressive multiple sclerosis
Background and purpose: The modifiable risk factor cigarette smoking has been associated with an increased risk of developing multiple sclerosis (MS) and with disease activity in relapsing−remitting MS. However, less is known about the effect of smoking on disease progression in progressive MS. Here the association between cigarette smoking and disability accumulation in primary progressive MS (PPMS) is investigated.Methods: Kaplan–Meier survival analyses and Cox proportional hazard modelling were used to investigate the influence of cigarette smoking on the risk of reaching Expanded Disability Status Scale (EDSS) 4 and 6 as well as the time from EDSS 4 to 6 in patients with PPMS.Results: In all, 416 patients with PPMS and available smoking history were identified. Median time to EDSS 4 was 4 years in ever‐smokers and 5 years in never‐smokers (P = 0.27), and it was 9 years to EDSS 6 in both ever‐smokers and never‐smokers (P = 0.48). Smokers were not at increased risk of faster progression to EDSS 4, 6 and from EDSS 4 to 6. Age at disease onset was the strongest risk factor for progression to EDSS 4, 6 and from EDSS 4 to 6.Conclusions: Our investigation of a large and well‐characterized population based PPMS cohort suggests that cigarette smoking does not influence disability accumulation in PPMS. Our findings support the idea that PPMS is driven by different underlying pathomechanisms than relapsing−remitting MS.
- 26 February 2017
- Published by Wiley in European Journal of Neurology
- Vol. 24 (4) , 624-630
Smoking does not influence disability accumulation in primary progressive multiple sclerosis
Background and purpose: The modifiable risk factor cigarette smoking has been associated with an increased risk of developing multiple sclerosis (MS) and with disease activity in relapsing−remitting MS. However, less is known about the effect of smoking on disease progression in progressive MS. Here the association between cigarette smoking and disability accumulation in primary progressive MS (PPMS) is investigated.Methods: Kaplan–Meier survival analyses and Cox proportional hazard modelling were used to investigate the influence of cigarette smoking on the risk of reaching Expanded Disability Status Scale (EDSS) 4 and 6 as well as the time from EDSS 4 to 6 in patients with PPMS.Results: In all, 416 patients with PPMS and available smoking history were identified. Median time to EDSS 4 was 4 years in ever‐smokers and 5 years in never‐smokers (P = 0.27), and it was 9 years to EDSS 6 in both ever‐smokers and never‐smokers (P = 0.48). Smokers were not at increased risk of faster progression to EDSS 4, 6 and from EDSS 4 to 6. Age at disease onset was the strongest risk factor for progression to EDSS 4, 6 and from EDSS 4 to 6.Conclusions: Our investigation of a large and well‐characterized population based PPMS cohort suggests that cigarette smoking does not influence disability accumulation in PPMS. Our findings support the idea that PPMS is driven by different underlying pathomechanisms than relapsing−remitting MS.